Polymorphisms related to the GSTs’ genome cause changes in the molecular structure of the enzyme, affecting its stability and the variability of enzymatic activity and detoxification capacity, which may lead to various types of cancer [195]. The gene discussed is HPGDS; the disease is cancer.